Study in Patients With COPD
NCT00215384
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
COPD
Interventions
DRUG:
Formoterol Fumarate
Sponsor
Dey